Inventor
HYEJIN CHUNG
Inventor
KR
Overview
Patents· 8 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes31%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations31%
C07KPeptides31%
G01NInvestigating or analysing materials by determining their chemical or physical properties8%
PatentTitleYear
12,252,541Anti-BCMA antibody and use thereof202512,240,913Anti-HER2/anti-4-1BB bispecific antibody and use thereof202512,195,538Anti-PD-L1/anti-4-1BB bispecific antibodies and uses thereof202512,195,537Anti-4-1BB antibody and use thereof202512,168,690Anti-EGFR/anti-4-1BB bispecific antibody202412,122,830Anti-ROR1 antibody and use thereof202412,071,483Bispecific antibody to alpha-synuclein/insulin-like growth factor 1 receptor and use thereof202411,891,445Anti-B7-H3 antibody and use thereof2024Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2024–2025Patents assigned to ABL BIO INC (8)· patent assignee history
2024–2025Patents assigned to YUHAN CORP (2)· patent assignee history
2024–2025Based in KR· patent location history
2025Patents assigned to I MAB BIOPHARMA US LTD (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ABL BIO INC | 8 | 2024–2025 |
| YUHAN CORP | 2 | 2024–2025 |
| I MAB BIOPHARMA US LTD | 1 | 2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| KR | 8 | 2024–2025 |